Cointime

Thetis Pharmaceuticals

company

About

Thetis Pharmaceuticals is a biopharmaceutical company.

Highlights

Total Funding Amount
$22.87M
Funding Rounds
9
Investors
5
Employee Profiles
7

Details

Last Funding Type
Grant
Last Funding Money Raised
$2.30M
Industries
Biotechnology,Clinical Trials,Medical,Pharmaceutical
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active
Legal Name
Thetis Pharmaceuticals LLC

Thetis Pharmaceuticals LLC is a biopharmaceutical company developing novel small molecule drugs to treat inflammatory diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
9
$22.87M
Thetis Pharmaceuticals has raised a total of $22.87M in funding over 2 rounds. Their latest funding was raised on Apr 5, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 5, 2022 Grant $4.20M 1 The Leona M. and Harry B. Helmsley Charitable Trust — Detail
Oct 24, 2019 Grant $2.30M 1 National Institutes of Health — Detail
May 23, 2018 Grant $1.90M 1 National Institutes of Health — Detail
Nov 16, 2017 Grant $2.30M 1 National Institutes of Health — Detail
Jun 27, 2016 Series Unknown $3.33M — — — Detail
Show More

Investors

Number of Lead Investors
Number of Investors
4
5
Thetis Pharmaceuticals is funded by 5 investors. The Leona M. and Harry B. Helmsley Charitable Trust and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
The Leona M. and Harry B. Helmsley Charitable Trust Yes Grant
National Institutes of Health Yes Grant
River Valley Investors — Series Unknown
Connecticut Innovations — Seed
Stonehenge Capital — Seed

Employee Profiles

Number of Employee Profiles
7
Thetis Pharmaceuticals has 7 current employee profiles, including Board member Elena A. Prokupets
Elena A. Prokupets
Board member
Ronald Lennox
Board member
Dennis Willson
Board member
Walter C. Ogier
Board member
Gary Mathias
Executive
Show More
Cointime
เนื้อหา
บริษัท